| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-541 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate |
2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14bdfacaf325f6a43ab50f8f82da8ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d88f43768c68aa732b3adc25c6ad4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc644046fd8d2182cb4e7b012ce066a |
| publicationDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3459538-A1 |
| titleOfInvention |
Crystalline salts of a dextroamphetamine prodrug |
| abstract |
The present invention relates to crystalline salts of L -lysine- d -amphetamine and to a pharmaceutical composition comprising one or more of said crystalline salts, preferably in a predetermined and/or effective amount, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) and Binge Eating Disorder (BED) symptoms.n nA is selected from the group consisting of adipic acid, p-toluene sulfonic acid, fumaric acid and oxalic acid. |
| priorityDate |
2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |